Antiviral effects of antisense RNA on hepatitis C virus RNA translation and expression

Journal of Medical Virology

Volumn 57, Issue 3, 1999, Pages 217-222

  Wakita, Takaji ^a,b   Moradpour, Darius ^a,c   Tokushihge, Katsutoshi ^a,d   Wands, Jack R ^a,e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c UNIVERSITY OF FREIBURG   (Germany)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

Antisense RNA; Core luciferase fusion; Hepatitis C

Indexed keywords

ALPHA INTERFERON; COMPLEMENTARY DNA; COMPLEMENTARY RNA; CORE PROTEIN; DNA HYBRID; HYBRID PROTEIN; VIRUS RNA;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SPECIFICITY; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN SYNTHESIS INHIBITION; RNA TRANSLATION; SEQUENCE ANALYSIS; VIRUS INHIBITION; VIRUS MUTATION;

ANIMALS; ANTIVIRAL AGENTS; ARTIFICIAL GENE FUSION; GENE EXPRESSION REGULATION, VIRAL; HEPACIVIRUS; HUMANS; LUCIFERASES; PROTEIN BIOSYNTHESIS; RABBITS; RNA, ANTISENSE; RNA, VIRAL; TUMOR CELLS, CULTURED;

ANIMALIA; CUCUMBER MOSAIC VIRUS; HEPATITIS C VIRUS; ORYCTOLAGUS CUNICULUS; RNA VIRUSES; VIBRIO PHAGE NT-1;

EID: 0032932079     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199903)57:3<217::AID-JMV1>3.0.CO;2-X     Document Type: Article

References (31)

1. Alt M, Renz R, Hofschneider P, Paumgartner G, Caselmann W. 1995. Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides. Hepatology 33: 707-717.
2. Ausubel F, Brent R, Kingston R, Moore D, Siedman J, Smith J, Struhl K. 1989. Current Protocols in Molecular Biology. New York: John Wiley & Sons.
3. Baltimore D. 1988. Intracellular immunization. Nature 335:395-396.
4. Brown E, Zhang H, Ping L, Lemon S. 1992. Secondary structure of the 5' non-translated regions of hepatitis C virus and pestivirus genomic RNAs. Nucl Acid Res 20:5041-5045.
5. Chatterjee S, Johnson P, Wong KJ. 1992. Dual-target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector. Science 258:1485-1488.
6. Chen C, Okayama H. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745-2752.
7. Choo Q, Kuo G, Weiner A, Overby L, Bradley D, Houghton M. 1989. Isolation of cDNA derived from blood-borne non-A, non-B viral hepatitis. Science 244:359-362.
8. Esteban J, Gonzales A, Hernandez J, Viladomiu L, Sanchez C, Lopez-Talavera J, Lucea D, Martin-Vega C, Vidai X, Esteban R, Guardia J. 1990. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 323:1107-1112.
9. Hanecak R, Brown-Driver V, Fox M, Azad R, Furusako S, Nozaki C, Ford C, Sasmor H, Anderson K. 1996. Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes. J Virol 70:5203-5212.
10. Izant J, Weintraub H. 1984: Inhibition of thymidine kinase gene expression by antisense RNA: a molecular approach to genetic analysis. Cell 1984:1007-1015.
11. Kakumu S, Yoshioka K, Wakita T, Ishikawa T, Takayanagi M, Higashi Y. 1993. A pilot study of ribarvirin and interferon beta for the treatment of chronic hepatitis C. Gastroenterology 105:507-512.
12. Katayama T, Kikuchi S, Tanaka Y, Saito I, Miyamura T, Choo Q, Houghton M, Kuo G. 1990. Blood screening for non-A, non-B hepatitis by hepatitis C virus antibody assay. Transfusion 30:374-376.
13. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell R, Alter H. 1990. Interrelationship of blood transfusion, non-A, non-B hepatitis C virus. Hepatology 12:671-675.
14. Koschel K, Brinckmann U, v Hoyningen-Huene V. 1995. Measles virus antisense sequences specifically cure cells persistently infected with measles virus. Virology 207:168-178.
15. Kuo G, Choo Q, Alter H, Gitnick G, Redeker A, Ourcell R, Miyamura T, Dienstag J, Alter M, Stevens C, Tegtmeier G, Bonino F, Colombo M, Lee W, Kuo C, Berger K, Shuster J, Overby L, Bradley D, Houghton M. 1989. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362-364.
16. Lanford R, Sureau C, Jacob J, White R, Fuerst T. 1994. Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strad-specific RT/PCR. Virology 606-614.
17. Milligan J, Matteucci M, Martin JC. 1993. Current concepts in antisense drug design. J Med Chem 36:1923-1937.
18. Mizutani T, Kato N, Hirota M, Sugiyama K, Murakami A, Shimotohno K. 1995. Inhibition of hepatitis C virus replication of antisense oligonucleotide in culture cells. Biochem Biophys Res Commun 212:906-11.
19. Moradpour D, Englert C, Wakita T, Wands J. 1996. Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. Virology 222:51-63.
20. Moradpour D, Wakita T, Tokushige K, Carlson R, Krawczynski K, Wands J. 1997. Establishment and characterization of three novel monoclonal antibodies to hepatitis C virus core protein. J Med Virol 48:234-241.
21. Reynolds J, Kaminski A, Kettinen H, Grace K, Clarke B, Caroll A, Rowlands D, Jackson R. 1995. Unique feature of internal initiation of hepatitis C virus RNA translation. EMBO J 14:6010-6020.
22. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y, Choo Q, Houghton M, Kuo G. 1990. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci 87:6547-6549.
23. Scaglioni P, Melegari M, Takahashi M, Chowdhury J, Wands J. 1996. Use of dominant negative mutants of the hepadnaviral core protein as antiviral agents. Hepatology 16:293-299.
24. Seki M, Honda Y. 1995. Phosphorothioate antisense oligodeoxynucleotides capable of inhibiting hepatitis C virun gene expression: in vitro translation assay. J Biochem 118:1199-1204.
25. Stein C, Cheng Y. 1993. Antisense oligonucleotides as therapeutic agents - is the bullet really magical? Science 261:1004-1012.
26. Tonkinson J, Stein C. 1993. Antisense nucleic acids: prospects for antiviral intervention. Antivir Chem Chemther 4:89-94.
27. Tsukiyama-Kohara K, Iizuka N, Kohara M, Nomoto A. 1992. Internal ribosome entry site within hepatitis C virus RNA. J Virol 66:1476-1483.
28. Vidalin O, Major M, Rayner B, Imbach J, Trepo C, Inchauspe G. 1996. In vitro inhibition of hepatitis C virus gene expression by chemically modified antisense oligodeoxynucleotides. Antimcrob Agents Chemother 40:2337-2344.
29. Wakita T, Wands J. 1994. Specific inhibition of hepatitis C virus expression by antisense oligodeoxynucleotides. J Biol Chem 269: 14205-14210.
30. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y, Shibata M, Morishima T. 1992. Detection of hepatitis C virus by polymerase chain reaction and response to interferonalpha therapy: relationship to genotypes of hepatitis C virus. Hepatology 16:293-299.
31. Zabner J, Couture LA, Gregory RJ, Graham SM, Smith AE, Welsh MJ. 1993. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75:207-216.